Skip to content Skip to footer

Home » Products » Oncology Genetic Tests » Early Colorectal Cancer Detection

Oncology Genetic Testing

Early Colorectal Cancer Detection

COLOTECT 1.0 is a non-invasive, highly sensitive screening test for colorectal cancer (CRC) and precancerous lesions. Human DNA is extracted from self-collected stool samples at home and used for the multiplex methylation specific PCR to detect abnormal CRC gene markers (SDC2, ADHFE1, PPP2R5C).

Oncology-Genetic-Testing

COLOTECT offers high accuracy with 92% specificity and 88% and 46% sensitivity for detecting colorectal cancer and adenoma, respectively. It is also highly convenient, allowing individuals to collect samples in the comfort of their homes. COLOTECT is designed to further advance the possibility of early detection and prevention. This is a precise, reliable, patient-friendly alternative to traditional screening methods

Subscribe To Our Newsletter

Newsletter

Member of Axis Healthcare Group

Address

Goldcrest Executive – Office: 1911 – Cluster C – Jumeirah Lake Towers 

Dubai – United Arab Emirates

Copyright ©2025 All rights reserved | Axis Healthcare.